A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
Clinical trial NCT05405660 · COMPLETED
Trial details
- NCT number
- NCT05405660
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2024-06-12
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.